Back to search

University of Leeds

Phenotype-Directed Discovery of Antibacterials

Abstract

dc:description.abstract

With antibacterial resistance on the rise, there is an urgent need for new, effective, and safe antibiotics to be brought to clinic as quickly as possible. Although many antibiotics have been developed using conventional drug development approaches, these have their limitations, with drug attrition rates >95%. Activity-directed synthesis (ADS) is one technique developed to speed up early drug development and reduce the time invested in the development of inactive compounds. Catalytic reactions are harnessed, as they can form multiple different products from common substrates, and reactions are performed in a microscale format, with mixtures being screened, without purification, against the selected target. This thesis initially shows how ADS, driven by a phenotypic assay, can be harnessed to expand the structure-activity relationships (SAR) of a class of antibacterials by designing, executing, and screening an array of 200 reactions based on Pd-catalysed carbonylation chemistry, without purification of individual products. LC-MS analysis of a random 10% of reaction wells confirmed significant conversion to bioactive products. Results show the discovery of new micromolar active antibacterial ligands based on a 4(3H)-quinazolinone core that possess antibacterial activity against multiple strains of S. aureus. Scale-up reactions were prioritised according to activity, and the structure of these products was elucidated. This approach therefore enabled rapid and efficient expansion of the SAR of antibacterials. ADS was also utilised to aid in the discovery of novel antibacterial chemotypes. This was possible as arrays were designed with no known antibacterial fragments incorporated into them. Two arrays, with a total of 375 reactions based on Rh carbenoid chemistry were performed and mixtures were screened directly against S. aureus. After scale-up and purification, novel antibacterial compounds with micromolar activity were identified, confirming this approach could aid in antibacterial drug development. Active compounds were further assessed for both eukaryotic toxicity and activity against different bacterial strains to assess their use as an antibacterial. It was demonstrated that ADS also aided in the discovery of new chemosynthetic pathways to antibacterials. This project confirmed ADS has the potential to be of more general value in the discovery of new antibacterial classes.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Leggott, Abbie Louise
Advisors dc:contributor.advisor
  • Nelson, Adam
  • Warriner, Stuart

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
EP/N025652/1

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Leggott, Abbie Louise. Phenotype-Directed Discovery of Antibacterials. doctoral thesis, University of Leeds, 2021.